Contemporary views of the mechanisms for development of myofascial pain syndrome and its treatment strategies
https://doi.org/10.14412/2074-2711-2020-6-83-89
Abstract
Myofascial pain syndrome (MFPS) is a regional pain syndrome that can be diagnosed in any age group and is characterized by the presence of a trigger point in the muscle involved in the pathological process. Clarifying the molecular mechanisms of trigger point formation and dysregulation of specific skeletal muscle proteins is important to understand the causes of abnormal sarcomere contraction observed in myofascial pain. Wide variability in using the diagnostic criteria in some cases leads to the impossibility of performing a meta-analysis of the data; in this connection, the search for the gold standard for MFPS diagnosis is actively underway. At the moment, a special clinical examination is of paramount diagnostic value. The paper considers various treatment options for myofascial pain and discusses the priority importance of using nonsteroidal anti-inflammatory drugs and muscle relaxants, as well as non-drug therapies.
Supporting agencies: This article has been supported by Gedeon Richter
About the Authors
G. R. Tabeeva
I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia
Russian Federation
Russian Federation
Gyuzyal Rafkatovna Tabeeva
Department of Nervous System Diseases and Neurosurgery
11, Rossolimo St., Build. 1, Moscow 119021
E. A. Kiryanova
I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia
Russian Federation
Russian Federation
Department of Nervous System Diseases and Neurosurgery
11, Rossolimo St., Build. 1, Moscow 119021
References
1. Fleckenstein J, Zaps D, Riger LJ, et al. Discrepancy between prevalence and perceived effectiveness of treatment methods in myofascial pain syndrome: results of a cross-sectional, nationwide survey. BMC Musculoskelet Disord. 2010;11:32. doi: 10.1186/1471-2474-11-32
2. Bagg JE Jr. The President's physician. Tex Heart Inst J. 2003;30(1):1-2.
3. Travell JG, Simons DG. Myofascial pain and dysfunction: the trigger point manual. Baltimore: Williams and Wilkins; 1983.
4. Stoop R, Clijsen R, Leoni D, et al. Evolution of the methodological quality of controlled clinical trials for myofascial trigger point treatments for the period 1978–2015: A systematic review. Musculoskelet Sci Pract. 2017; 30:1-9. doi:10.1016/j.msksp.2017.04.009
5. Sterud T, Johannessen HA, Tynes T. Work-related psychosocial and mechanical risk factors for neck/shoulder pain: a 3-year followup study of the general working population in Norway. Int Arch Occup Environ Health. 2014 Jul;87(5):471-81. doi: 10.1007/s00420-013-0886-5. Epub 2013 May 26.
6. Hall BH. Chronic Myofascial Pain, Fibromylagia, and Myofascial Trigger Points. In Evaluation and Management of Chronic Pain for Primary Care. Springer, Cham; 2020. P. 245-53.
7. Saxena A, Chansoria M, Tomar G, Kumar A. Myofascial pain syndrome: an overview. J Pain Palliat Care Pharmacother. 2015 Mar;29(1):16-21. doi: 10.3109/15360288.2014.997853. Epub 2015 Jan 5.
8. Bron C, Dommerholt JD. Etiology of myofascial trigger points. Curr Pain Headache Rep. 2012 Oct;16(5):439-44. doi: 10.1007/s11916-012-0289-4
9. Gerwin RD, Dommerholt J, Shah JP. An expansion of Simons' integrated hypothesis of trigger point formation. Curr Pain Headache Rep. 2004;8(6):468-75. doi: 10.1007/s11916-004-0069-x
10. Quintner JL, Bove GM, Cohen ML. A critical evaluation of the trigger point phenomenon. Rheumatology (Oxford). 2015;54(3):392-9. doi: 10.1093/rheumatology/keu471. Epub 2014 Dec 3.
11. Fernandez-de-las-Penas C, Dommerholt J. Myofascial trigger points: peripheral or central phenomenon? Curr Rheumatol Rep. 2014;16(1):395. doi: 10.1007/s11926-013-0395-2
12. Srbely JZ, Kumbhare D, Grosman-Rimon L. A narrative review of new trends in the diagnosis of myofascial trigger points: diagnostic ultrasound imaging and biomarkers. J Can Chiropr Assoc. 2016 Sep;60(3): 220-5.
13. Bourgaize S, Newton G, Kumbhare D, Srbely J. A comparison of the clinical manifestation and pathophysiology of myofascial pain syndrome and fibromyalgia: implications for differential diagnosis and management. J Can Chiropr Assoc. 2018;62(1):26-41.
14. Larsson SE, Bengtsson A, Bodegard L, et al. Muscle changes in work-related chronic myalgia. Acta Orthop Scand. 1988 Oct;59(5):552-6. doi: 10.3109/17453678809148783
15. Windisch A, Reitinger A, Traxler H, et al. Morphology and histochemistry of myogelosis. Clin Anat. 1999;12(4):266-71. doi: 10.1002/(SICI)1098-2353(1999)12:43.0.CO;2-G
16. Akamatsu FE, Ayres BR, Saleh SO, et al. Trigger points: an anatomical substratum. Biomed Res Int. 2015;2015:623287. doi: 10.1155/2015/623287. Epub 2015 Feb 24.
17. Huang QM, Ye G, Zhao ZY, et al. Myoelectrical activity and muscle morphology in a rat model of myofascial trigger points induced by blunt trauma to the vastus medialis. Acupunct Med. 2013;31:65-73. doi: 10.1136/acupmed-2012-010129
18. Mense S, Simons DG, Hoheisel U, Quenzer B. Lesions of rat skeletal muscle after local block of acetylcholinesterase and neuromuscular stimulation. J Appl Physiol (1985). 2003 Jun;94(6):2494-501. doi: 10.1152/japplphysiol.00727.2002. Epub 2003 Feb 7.
19. Ga H, Koh HJ, Choi JH, Kim CH. Intramuscular and nerve root stimulation vs lidocaine injection to trigger points in myofascial pain syndrome. J Rehabil Med. 2007 May;39(5):374-8. doi: 10.2340/16501977-0058
20. Ernberg M, Hedenberg-Magnusson B, List T, Svensson P. Efficacy of botulinum toxin type A for treatment of persistent myofascial TMD pain: a randomized, controlled, doubleblind multicenter study. Pain. 2011;152:1988- 96. doi: 10.1016/j.pain.2011.03.036
21. Grosman-Rimon L, Parkinson W, Upadhye S, et al. Circulating biomarkers in acute myofascial pain: a case-control study. Medicine (Baltimore). 2016 Sep;95(37):e4650. doi: 10.1097/MD.0000000000004650
22. Shah JP, Gilliams EA. Uncovering the biochemical milieu of myofascial trigger points using in vivo microdialysis: an application of muscle pain concepts to myofascial pain syndrome. J Bodyw Mov Ther. 2008 Oct;12(4):371- 84. doi: 10.1016/j.jbmt.2008.06.006. Epub 2008 Aug 13.
23. Fischer MJ, Horvath G, Krismer M, et al. Evaluation of mitochondrial function in chronic myofascial trigger points-a prospective cohort pilot study using high-resolution respirometry. BMC Musculoskelet Disord. 2018;19(1): 388. doi: 10.1186/s12891-018-2307-0
24. Jin F, Guo Y, Wang Z, et al. The pathophysiological nature of sarcomeres in trigger points in patients with myofascial pain syndrome: a preliminary study. Eur J Pain. 2020 Aug 25. doi: 10.1002/ejp.1647. Online ahead of print.
25. Tolias KF, Bikoff JB, Kane CG, et al. The Rac1 guanine nucleotide exchange factor Tiam1 mediates EphB receptor-dependent dendritic spine development. Proc Natl Acad Sci U S A. 2007 Apr 24;104(17):7265-70. doi: 10.1073/pnas.0702044104. Epub 2007 Apr 17.
26. Rivat C, Sar C, Mechaly I, et al. Inhibition of neuronal FLT3 receptor tyrosine kinase alleviates peripheral neuropathic pain in mice. Nat Commun. 2018 Mar 12;9(1):1042. doi: 10.1038/s41467-018-03496-2
27. Trampas A, Kitsios A, Sykaras E, et al. Physical therapy in sport clinical massage and modified proprioceptive neuromuscular facilitation stretching in males with latent myofascial trigger points. Phys Ther Sport. 2010;11(3):91-8. doi: 10.1016/j.ptsp.2010.02.003
28. Ge H-Y, Arendt-Nielsen L, Madeleine P. Accelerated muscle fatigability of latent myofascial trigger points in humans. Pain Med. 2012 Jul;13(7):957-64. doi: 10.1111/j.1526-4637.2012.01416.x. Epub 2012 Jun 13.
29. Simons DG, Travell JG, Simons LS. Travell and Simons' myofascial pain and dysfunction the trigger point manual. In: Upper half of body. 2nd ed. Baltimore: Williams & Wilkins; 1999. Vol. 1.
30. Harden R, Bruehl S, Gass S, et al. Signs and symptoms of the myofascial pain syndrome: a national survey of pain management providers. Clin J Pain. 2000 Mar;16(1):64-72. doi: 10.1097/00002508-200003000-00010
31. Tough EA, White AR, Richards S, Campbell J. Variability of criteria used to diagnose myofascial trigger point pain syndrome - evidence from a review of the literature. Clin J Pain. 2007;23(3):278-86. doi: 10.1097/AJP.0b013e31802fda7c
32. Li L, Stoop R, Clijsen R, et al. Criteria Used for the Diagnosis of Myofascial Trigger Points in Clinical Trials on Physical Therapy: Updated Systematic Review. Clin J Pain. 2020 Dec;36(12):955-67. doi: 10.1097/AJP.0000000000000875
33. Fernandez-de-las-Penas C, Dommerholt J. International Consensus on Diagnostic Criteria and Clinical Considerations of Myofascial Trigger Points: A Delphi Study. Pain Med. 2017;19(1):142-50. doi: 10.1093/pm/pnx207
34. Adigozali H, Shadmehr A, Ebrahimi E, et al. B mode, Doppler and ultrasound elastography imaging on active trigger point in women with myofascial pain syndrome treated by dry needling. Musc Lig Tend J. 2019; 9(3):417-24. doi: 10.32098/mltj.03.2019.16
35. Partanen J. Electromyography in myofascial syndrome. EMG Methods for Evaluating Muscle and Nerve Function. 2012. 55 p.
36. Rainsford K. Profile and mechanisms of gastrointestinal and other side effects of nonsteroidal anti-inflammatory drugs (NSAIDs). Am J Med. 1999 Dec 13;107(6A):27S-35S; discussion 35S-36S. doi: 10.1016/s0002-9343(99)00365-4
37. Affaitati G, Costantini R, Tana C, et al. Effects of topical vs injection treatment of cervical myofascial trigger points on headache symptoms in migraine patients: a retrospective analysis. J Headache Pain. 2018;19:104. doi: 10.1186/s10194-018-0934-3
38. Yevdokimova YeM, Shagbazyan AE, Tabeyeva GR. Myofascial pain syndrome: clinical and pathophysiological aspects and effective pain. Effektivnaya farmakoterapiya. 2017;38:18- 27 (In Russ.).
39. Huang-Lionnet JH, Hameed H, Cohen SP. Pharmacologic management of myofascial pain. Essentials PainMed. 4th ed. Elsevier; 2018. P. 475-84e.
40. Rozhkov DO, Zinovyeva OE, Barinov AN, et al. Myofascial pain syndrome in female patients with chronic nonspecific back pain: diagnosis and treatment. Nevrologiya, neyropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2020;12(2):57- 63. doi: 10.14412/2074-2711-2020-2-57-63 (In Russ.).
41. Devlikamova FI. Results of the post-registration clinical study «PARUS» on efficiency and safety assessment of mydocalm-richter for local injection therapy of a myofascial trigger zone. Terapevticheskiy arkhiv. 2018;90(6):81-8. doi: 10.26442/terarkh2018906122-129 (In Russ.).
42. Heir GM. The efficacy of pharmacologic treatment of Temporomandibular disorders. Oral Maxillofac Surg Clin North Am. 2018 Aug;30(3):279-85. doi: 10.1016/j.coms.2018.05.001. Epub 2018 Jul 5.
43. Khalifeh M, Mehta K, Varguise N, et al. Botulinum toxin type A for the treatment of head and neck chronic myofascial pain syndrome. J Am Dent Assoc. 2016 Dec;147(12):959- 73.e1. doi: 10.1016/j.adaj.2016.08.022. Epub 2016 Oct 10.
44. Kalichman L, Ben DC. Effect of selfmyofascial release on myofascial pain, muscle flexibility, and strength: a narrative review. J Bodyw Mov Ther. 2017 Apr;21(2):446-51. doi: 10.1016/j.jbmt.2016.11.006. Epub 2016 Nov 14.
45. Liu L, Huang Q-M, Liu Q-G, et al. Evidence for dry needling in the management of myofascial trigger points associated with low back pain: a systematic review and meta-analysis. Arch Phys Med Rehabil. 2018 Jan;99(1):144- 52.e2. doi: 10.1016/j.apmr.2017.06.008. Epub 2017 Jul 8.
46. Gerber LH, Sikdar S, Aredo JV, et al. Beneficial effects of dry needling for treatment of chronic myofascial pain persist for 6 weeks after treatment completion. PM R. 2017 Feb;9(2):105-112. doi: 10.1016/j.pmrj.2016.06.006. Epub 2016 Jun 11.
47. Wang R, Li X, Zhou S, et al. Manual acupuncture for myofascial pain syndrome: a systematic review and metaanalysis. Acupunct Med. 2017 Aug;35(4):241-50. doi: 10.1136/acupmed-2016-011176. Epub 2017 Jan 23.
48. Kukushkin ML. A modern look at the mechanism of action of Mydocalm®. Lechebnoye delo: nauchno-prakticheskiy terapevticheskiy zhurnal. 2013;(2):7-12 (In Russ.).
49. Gerwin RD, Cagnie B, Petrovic M, et al. Foci of Segmentally Contracted Sarcomeres in Trapezius Muscle Biopsy Specimens in Myalgic and Nonmyalgic Human Subjects: Preliminary Results. Pain Med. 2020 Oct;21(10):2348-56. doi: 10.1093/pm/pnaa019. Epub 2020 Apr 14.
50. Yakhno NN, Kukushkin ML. Bol' (prakticheskoye rukovodstvo dlya vrachey) [Pain (a practical guide for doctors)]. Moscow: Izdatel'stvo RAMN; 2011. 512 p. (In Russ.).
Review
For citations:
Tabeeva GR, Kiryanova EA. Contemporary views of the mechanisms for development of myofascial pain syndrome and its treatment strategies. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2020;12(6):83-89. (In Russ.) https://doi.org/10.14412/2074-2711-2020-6-83-89
Views:
714
Email this article 